跳至主要内容
临床试验/ACTRN12617001317381
ACTRN12617001317381招募中2 期

A Randomised Placebo Controlled Trial of Estradiol for the Treatment of Women with Borderline Personality Disorder

Alfred Hospital0 个研究点目标入组 72 人开始时间: 2017年9月13日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 43 Years(—)
性别
Female

入选标准

  • – Age 18-43 years
  • – Primary diagnosis of BPD, assessed by the Diagnostic Interview for Borderline Patients (DIB-R)
  • – Be willing to use appropriate barrier contraceptive precaution for the duration of the study

排除标准

  • Known history of breast, endometrial or ovarian cancer
  • Women aged 40 or over who have not had a normal mammogram in the last 24 months
  • Abnormal pap smear in the last 24 months
  • Contraindications to estradiol
  • Current pregnancy or trying to become pregnant,
  • History of blood clots (e.g. deep vein thrombosis, pulmonary embolism)
  • Previous arterial thromboembolic disease (e.g. stroke)
  • Acute, high risk of suicide such that inpatient admission is required, as determined by PI Kulkarni (psychiatrist) based on her expert clinical assessment.
  • Taking more than 5 psychotropic medications
  • Taking OCP that do not have 20, 30 or 35mcg estradiol component
  • New/ planned changes to psychotropic medication/psychotherapy plans
  • Consistent, severe substance abuse in last 3 months
  • Smoking more than 20 cigarettes per day

研究者

发起方
Alfred Hospital

相似试验

Estrogen for the treatment of Borderline Personality... | 临床试验